| 产品名称 |
Recombinant Human KLK13 (C-6His) |
| 英文名称 |
Kallikrein 13/KLK13 |
| 纯度 |
Greater than 95% as determined by reducing SDS-PAGE |
| 内毒素 |
<1 EU/µg as determined by LAL test. |
| 蛋白构建 |
Recombinant Human Kallikrein 13 is produced by our Mammalian expression system and the target gene encoding Gly17-Ile262 is expressed with a 6His tag at the C-terminus. |
| Accession |
Q9UKR3 |
| 表达宿主 |
Human Cells |
| 种属 |
Human |
| 预测分子量 |
28.03 KDa |
| 制剂 |
Supplied as a 0.2 μm filtered solution of 20mM MES, 150mM NaCl, 10% Glycerol, pH 5.5. |
| 运输方式 |
The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below. |
| 稳定性&储存 |
Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| 复溶 |
| 分子别名 |
| Kallikrein-13; Kallikrein-Like Protein 4; KLK-L4; KLK13; KLKL4 |
| 背景介绍 |
| Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many Kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen Kallikrein subfamily members located in a cluster on chromosome 19. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers. Alternate splicing of this gene results in multiple transcript variants encoding the same protein. |
注意事项
本司产品仅用于科研，不用于临床诊断和治疗
